FDAnews
www.fdanews.com/articles/206039-microport-scientifics-navigo-cardiac-devices-receive-ce-mark

MicroPort Scientific’s Navigo Cardiac Devices Receive CE Mark

January 5, 2022

Clamart, France-based MicroPort CRM (cardiac rhythm management) has received a CE mark for two additions to its Navigo range of left ventricular-pacing leads.

The thin-diameter Navigo 4LV ARC and Navigo 4LV 2D leads are designed to provide physicians with a variety of options for pacing the left ventricle when connected to an implantable cardiac resynchronization device.

Cardiac resynchronization therapy has been shown to improve survival and quality of life, and to reduce hospitalization in heart failure patients.

View today's stories